Laxminarayan Bhat
2023
In 2023, Laxminarayan Bhat earned a total compensation of $2.8M as Chief Executive Officer and President at REVIVA PHARMACEUTICALS HOLDINGS, a 394% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $157,500 |
---|---|
Option Awards | $2,157,247 |
Salary | $450,000 |
Total | $2,764,747 |
Bhat received $2.2M in option awards, accounting for 78% of the total pay in 2023.
Bhat also received $157.5K in non-equity incentive plan and $450K in salary.
Rankings
In 2023, Laxminarayan Bhat's compensation ranked 330th out of 2,770 executives tracked by ExecPay. In other words, Bhat earned more than 88.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 330 | 88th |
Manufacturing | 186 | 88th |
Chemicals And Allied Products | 128 | 85th |
Drugs | 125 | 85th |
Pharmaceutical Preparations | 78 | 87th |
Bhat's colleagues
We found one more compensation record of an executive who worked with Laxminarayan Bhat at REVIVA PHARMACEUTICALS HOLDINGS in 2023.
2023
Narayan Prabhu
REVIVA PHARMACEUTICALS HOLDINGS